These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31897214)

  • 1. Identification of key candidate tumor biomarkers in non-small-cell lung cancer by
    Chen W; Zhu S; Zhang Y; Xiao J; Tian D
    Oncol Lett; 2020 Jan; 19(1):1008-1016. PubMed ID: 31897214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hub genes and key pathways of non-small lung cancer identified using bioinformatics.
    Tang Q; Zhang H; Kong M; Mao X; Cao X
    Oncol Lett; 2018 Aug; 16(2):2344-2354. PubMed ID: 30008938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of key genes associated with non-small-cell lung cancer.
    Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
    J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis.
    Shi Y; Li Y; Yan C; Su H; Ying K
    Oncol Lett; 2019 Dec; 18(6):5859-5870. PubMed ID: 31788059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation.
    Yin Y; Li D; He M; Wang J
    Transl Cancer Res; 2022 Aug; 11(8):2622-2635. PubMed ID: 36093542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
    Liu X; Liu X; Li J; Ren F
    Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of genes and pathways leading to poor prognosis of non-small cell lung cancer using integrated bioinformatics analysis.
    Cui S; Lou S; Feng J; Tang X; Xiao X; Huang R; Guo W; Zhou Y; Huang F
    Transl Cancer Res; 2022 Apr; 11(4):710-724. PubMed ID: 35571642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of novel biomarkers and candidate small molecule drugs in non-small-cell lung cancer by integrated microarray analysis.
    Wu Q; Zhang B; Sun Y; Xu R; Hu X; Ren S; Ma Q; Chen C; Shu J; Qi F; He T; Wang W; Wang Z
    Onco Targets Ther; 2019; 12():3545-3563. PubMed ID: 31190860
    [No Abstract]   [Full Text] [Related]  

  • 10. Common and distinct features of potentially predictive biomarkers in small cell lung carcinoma and large cell neuroendocrine carcinoma of the lung by systematic and integrated analysis.
    Dong S; Liang J; Zhai W; Yu Z
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1126. PubMed ID: 31981472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Candidate Biomarkers Correlated With the Pathogenesis and Prognosis of Non-small Cell Lung Cancer via Integrated Bioinformatics Analysis.
    Ni M; Liu X; Wu J; Zhang D; Tian J; Wang T; Liu S; Meng Z; Wang K; Duan X; Zhou W; Zhang X
    Front Genet; 2018; 9():469. PubMed ID: 30369945
    [No Abstract]   [Full Text] [Related]  

  • 12. Screening of hub genes associated with prognosis in non-small cell lung cancer by integrated bioinformatics analysis.
    Zeng Y; Li N; Chen R; Liu W; Chen T; Zhu J; Zeng M; Cheng J; Huang J
    Transl Cancer Res; 2020 Nov; 9(11):7149-7164. PubMed ID: 35117319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of key pathways and genes in the progression of cervical cancer using bioinformatics analysis.
    Wu K; Yi Y; Liu F; Wu W; Chen Y; Zhang W
    Oncol Lett; 2018 Jul; 16(1):1003-1009. PubMed ID: 29963176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
    Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
    Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.
    Chen FF; Zhang SR; Peng H; Chen YZ; Cui XB
    Mol Med Rep; 2019 Oct; 20(4):3649-3660. PubMed ID: 31485619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
    Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
    Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key differentially expressed mRNAs and microRNAs in non-small cell lung cancer using bioinformatics analysis.
    Wang W; Wang S; Pan L
    Exp Ther Med; 2020 Oct; 20(4):3720-3732. PubMed ID: 32855723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NUF2 Is a Potential Immunological and Prognostic Marker for Non-Small-Cell Lung Cancer.
    Li X; Zhang L; Yi Z; Zhou J; Song W; Zhao P; Wu J; Song J; Ni Q
    J Immunol Res; 2022; 2022():1161931. PubMed ID: 35600043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of differentially-expressed microRNAs and genes in cervical cancer using an integrated bioinformatics analysis.
    Xu Z; Zhou Y; Shi F; Cao Y; Dinh TLA; Wan J; Zhao M
    Oncol Lett; 2017 Apr; 13(4):2784-2790. PubMed ID: 28454467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.